Introduction Gynecologic oncology, the field dedicated to the diagnosis and treatment of cancers affecting the female reproductive system, faces persistent challenges in achieving optimal patient
Introduction For decades, gynecologic oncology has relied on a largely standardized approach to treating ovarian and uterine cancers. While effective in many cases, this “one-size-fits-all”
Introduction Uterine cancer, encompassing endometrial and uterine sarcoma, presents a significant global health challenge. Early detection is crucial for improving patient outcomes, yet current screening
Introduction Ovarian cancer, a disease characterized by its insidious onset and often late-stage diagnosis, remains a significant challenge in oncology. Says Dr. Scott Kamelle, traditional
Introduction A diagnosis of ovarian or uterine cancer can feel overwhelming, ushering in a flood of emotions and questions. While every patient’s experience is unique,
Introduction For decades, hysterectomy—the surgical removal of the uterus—was considered the primary and most effective treatment for uterine cancer. Says Dr. Scott Kamelle, while this approach
Introduction Gynecologic cancers, including ovarian, uterine, cervical, vulvar, and vaginal cancers, have long presented significant treatment challenges. Traditional approaches—surgery, chemotherapy, and radiation—remain vital, but recent
Introduction Genetic discoveries have revolutionized the understanding of gynecologic cancers, shedding light on why some individuals are more susceptible than others. Among the most recognized
Introduction Ovarian cancer is often referred to as the “silent killer” because its early symptoms are typically vague and easily mistaken for less serious conditions.
Introduction Ovarian and uterine cancers represent significant challenges in the oncology landscape. These diseases, often diagnosed at later stages, necessitate a multi-pronged approach encompassing advanced